Core Antimicrobial Stewardship Curriculum for Faculty

The IDSA Core Antimicrobial Stewardship (CAS) Curriculum was developed to provide infectious diseases (ID) fellows with foundational education and training in Antimicrobial
Stewardship (AS), regardless of ultimate career plans. The curriculum is designed for use within an existing ID fellowship training program to ensure the future ID workforce is equipped to oversee and participate in AS efforts.

The faculty version of the curriculum provides access to manage fellow completions and attendance, exclusive video content for classroom facilitation, and guidance on implementation. For additional details regarding faculty participation and the time commitment, please refer to the flyer at the bottom of this page.

The Core Antimicrobial Stewardship (CAS) Curriculum was featured in the November 2023 episode of Febrile. Check out the podcast below:

Target Audience

This course is designed specifically for ID training program directors, ID Pharmacists, AS medical directors, the designated Antimicrobial Stewardship Champion or other faculty members that will be implementing the AS curriculum for stewards in training.

Learning Objectives

Upon completion of this Curriculum, the learner should be able to:

1. Explain to patients and health care providers the importance of antibiotic stewardship in the care of individual patients and the community at large

2. Model antibiotic stewardship best practices during the clinical care of patients in the inpatient and outpatient setting

3. Structure a conversation to effect change in the antibiotic prescribing patterns of other providers using techniques based in behavioral psychology

4. Describe elements of an effective antibiotic stewardship program and explain the inter-professional collaborations and leadership support necessary for its success

5. Discuss antibiotic stewardship as a potential career pathway and explain the day to day activities of the antibiotic steward

Additional Information

Attachment	Size
CORE/Advanced AS Curriculum Flyer	172.72 KB
Institutional Purchasing for the AS Curriculum	514.96 KB
Enrolling As a Fellow or Faculty With a Code	409.08 KB

Course summary

Course opens:

07/01/2021

Course expires:

12/01/2025

IDSA Member cost:

$200.00

Non-member cost:

$300.00

Cost:

$300.00

AS Curriculum Workgroup COI Summary Reviewed April 2017 by Rachel Simmons, MD No conflicts found.

All relevant financial relationships have been mitigated.

Name	Individual's role in activity	Name of commercial interest	Nature of Relationship
Advani, Sonali	Workgroup Member	None
Armstrong, Wendy	Workgroup Member	None
Barsoumian, Alice	Workgroup Member	None
Beeler, Cole	Workgroup Member	None
Bennani, Kenza	Staff	None
Blair, Barbra	Workgroup Member	None
Brennan - Krohn, Thea	Workgroup Member	None
Bryson - Cahn, Chloe	Workgroup Member	None
Cherabuddi, Kartik	Workgroup Member	None
Fong, Gary	Workgroup Member	Critical Innovations, LLC	Advisory/Consultant Role
Gaston, David	Workgroup Member	None
Hamilton, Keith	Workgroup Member	None
Holubar, Marisa	Workgroup Member	None
Huang, Misha	Workgroup Member	None
Ince, Dilek	Workgroup Member	Gilead Science’s Clinical Studies for remdesivir	Principal Investigator
		Accelerate Diagnostics	Research Grants/Contracts
		Leidos	Research Grants/Contracts
Justo, Julie Ann	Workgroup Member	bioMerieux	Other remuneration - Speaker's Bureau
		Merck	Advisory/Consultant Role
		Vaxart	Stocks/Bonds
Kang, Amy	Workgroup Member	None
Larnard, Jeff	Workgroup Member	None
Lee, Matthew	Workgroup Member	None
Logan, Ashleigh	Staff	None
Luther, Vera	Workgroup Member	None
MacDougal, Conan	Workgroup Member	None
Melia, Michael	Workgroup Member	Merck	Organizational Benefit
		Allergan	Organizational Benefit
		Pfizer; Melinta	Organizational Benefit
Miller, Matt	Workgroup Member	Abbvie	Honoraria
		La Jolla	Honoraria
		Merck	Research Grant/Contract
Moenster, Ryan	Workgroup Member	Shionogi	Advisory/Consultant Role, Honoraria
		Abbvie/Allergan	Advisory/Consultant Role, Honoraria
		Melinta Therapeutics	Advisory/Consultant Role, Honoraria
		Merck	Advisory/Consultant Role, Honoraria
Nori, Priya	Workgroup Member	Merck	Co-infections in COVID-19 patients
Paras, Molly	Workgroup Member	None
Patel, Payal	Workgroup Member	None
Rodvold, Keith	Workgroup Member	BLC USA LP	Advisory/Consultant Role, Honoraria
		VenatoRx	Advisory/Consultant Role, Honoraria
		Medicine Company/Qpex Biopharma	Advisory/Consultant Role, Honoraria
		Vemco Med Ed. (Merck CME/CPE programs)	Advisory/Consultant Role, Honoraria
		Debipharm	Advisory/Consultant Role, Honoraria
		Shionogi	Advisory/Consultant Role, Honoraria
			Unrestricted education grant for CME/CPE Program
		Utility Therapeutics	Advisory/Consultant Role, Honoraria
		Janssen	Data Safety Monitoring Board (DSMB)
		Clinartis LLC (projects associated with Spero Therapeutics and Sinovent)	Advisory/Consultant Role, Honoraria
		USCAST : US Ctte on Antimicrobial Susceptibility Testing	Voting Committee Member
Schooneveld, Trevor	Workgroup Member	Rebiotix, Merk	Research Grant
		Thermo - Fischer	Speaking
Schwartz, Brian	Workgroup Member	None
Spicer, Jennifer	Workgroup Member	None
Stack, Conor	Workgroup Member	None
Stead, Wendy	Workgroup Member	None
Stohs, Erica	Workgroup Member	Reviral Ltd	Research Grant
Wiley, Zanthia	Workgroup Member	None
Willis, Zachary	Workgroup Member	None
Shnekendorf, Rachel	Staff	None
Vaezi, Liza	Workgroup Member	None
Rachel Simmons	Reviewer	None